Subject matters | Details | Categories |
---|---|---|
Budget, Health
|
Budget 2025 - as it relates to full and sustainable funding by the Government of Canada in: A Dementia Strategy for Canada: Together We Aspire
|
Policies or Program
|
Budget, Health
|
Canadian Institutes of Health Research (CIHR) - as it relates to increased federal funding and long-term investment in dementia research exceeding 1% of direct dementia care costs (aspirational goal in national dementia strategy)
|
Policies or Program
|
Health, Justice and Law Enforcement
|
Communications regarding medical assistance in dying with respect to advance requests, the state of palliative care, and the protection of Canadians with disabilities.
|
Legislative Proposal, Bill or Resolution, Policies or Program, Regulation
|
Budget, Health
|
Communications regarding potential funding to Alzheimer Society Research Program for research to study the topic of Veterans and Dementia in a truly Canadian context.
|
Grant, Contribution or Other Financial Benefit
|
Health
|
Communications regarding the Canada Disability Benefit to ensure accessibility for individuals with cognitive impairment, including with Alzheimer's or other dementias.
|
Policies or Program
|
Health, Labour
|
Communications regarding the Canada Post strike and its adverse financial impacts (i.e. donations) on the charitable sector.
|
Regulation, Policies or Program
|
Budget, Health
|
Communications regarding the need for $20 million over 5 years through programs like Age Well at Home, and a longer-term and larger
commitment to programs like ASC's FirstLink® that have been proven to support people with dementia to live well as long as possible at home and in the community.
|
Policies or Program, Grant, Contribution or Other Financial Benefit
|
Budget, Health
|
Communications regarding the need to invest $15 million over 3 years to implement national standards for diagnosis, treatment and care for Alzheimer’s disease and dementia. This will ensure that the health systems across the country have access to quality standards to be able to realize the benefits of any disease modifying drugs approved in Canada.
|
Policies or Program
|
Budget, Health
|
Create and fund programs to support Canadians diagnosed with young-onset dementia.
|
Policies or Program
|
Health
|
Funding opportunities under PHAC's Dementia Community Investment and Dementia Strategic Fund to support awareness-raising, dementia guidelines, diversity & Inclusion and best practices.
|
Grant, Contribution or Other Financial Benefit
|
Health
|
Health Canada as it pertains to the approval of disease-modifying treatments for Alzheimer's disease and other dementias that aim to slow or halt the progression of the disease.
|
Regulation, Policies or Program
|
Health
|
Implementation metrics and success criteria for "A Dementia Strategy for Canada:Together We Aspire."
|
Policies or Program
|
Health
|
Improve access to palliative and end-of-life care for people living with dementia in Canada.
|
Policies or Program
|
Health
|
National standards and Safe Long-term Care Act include a common standard for the definition of an Essential Care Partner (ECP).
|
Legislative Proposal, Bill or Resolution
|
The Alzheimer Society is Canada's leading health charity for people with Alzheimer's disease and related disorders. The Society works nationwide to improve the quality of life for Canadians living with dementia, their families and caregivers, and advances the search for the causes and a cure.
Sarah Calderwood, Vice President, Government Advocacy
End date of the last completed financial year: 2024-03-31
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
Employment & Social Development Canada | $906,842.00 | Yes |
Employment and Social Development Canada (ESDC) | $82,587.00 | Yes |
Public Health Agency of Canada | $917,510.00 | Yes |
Public Health Agency of Canada (PHAC) | $1,091,377.00 | Yes |
Address:
20 Eglinton Avenue West
16th Floor - 16ième étage
Toronto, ON M4R 1K8
Canada
Telephone number:
416-488-8772
Ext.
2936